<?xml version="1.0" encoding="UTF-8"?>
<ref id="B65-vaccines-07-00203">
 <label>65.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Dejnirattisai</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Jumnainsong</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Onsirisakul</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Fitton</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Vasanawathana</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Limpitikul</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Puttikhunt</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Edwards</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Duangchinda</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Supasa</surname>
    <given-names>S.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Cross-reacting antibodies enhance dengue virus infection in humans</article-title>
  <source>Science</source>
  <year>2010</year>
  <volume>328</volume>
  <fpage>745</fpage>
  <lpage>748</lpage>
  <pub-id pub-id-type="doi">10.1126/science.1185181</pub-id>
  <pub-id pub-id-type="pmid">20448183</pub-id>
 </element-citation>
</ref>
